Six substituted ligands based upon 2‐(naphthalen‐1‐yl)quinoline‐4‐carboxylate and 2‐(naphthalen‐2‐yl)quinoline‐4‐carboxylate have been synthesised in two steps from a range of commercially available isatin derivatives. These species are shown to be effective cyclometallating ligands for IrIII, yielding complexes of the form [Ir(C^N)2(bipy)]PF6 (where C^N=cyclometallating ligand; bipy=2,2′‐bipyridine). X‐ray crystallographic studies on three examples demonstrate that the complexes adopt a distorted octahedral geometry wherein a cis‐C,C and trans‐N,N coordination mode is observed. Intraligand torsional distortions are evident in all cases. The IrIII complexes display photoluminescence in the red part of the visible region (668–693 nm), which is modestly tuneable through the ligand structure. The triplet lifetimes of the complexes are clearly influenced by the precise structure of the ligand in each case. Supporting computational (DFT) studies suggest that the differences in observed triplet lifetime are likely due to differing admixtures of ligand‐centred versus MLCT character instilled by the facets of the ligand structure. Triplet–triplet annihilation upconversion (TTA‐UC) measurements demonstrate that the complexes based upon the 1‐naphthyl derived ligands are viable photosensitisers with upconversion quantum efficiencies of 1.6–6.7 %.

Ruthenium(II) polypyridyl complexes (RPCs) that emit from metal-to-ligand charge transfer (MLCT) states have been developed as DNA probes and are being examined as potential anticancer agents. Here, we report that MLCT-emissive RPCs that bind DNA undergo Förster resonance energy transfer (FRET) with Cy5.5-labeled DNA, forming mega-Stokes shift FRET pairs. Based on this discovery, we developed a simple and rapid FRET binding assay to examine DNA-binding interactions of RPCs with diverse photophysical properties, including non-“light switch” complexes [Ru(dppz)2(5,5′dmb)]2+ and [Ru(PIP)2(5,5′dmb)]2+ (dppz = dipyridophenazine, 5,5′dmb = 5,5′-dimethyl-2,2′-bipyridine, PIP = 2-phenyl-imidazo[4,5-f][1,10]phenanthroline). Binding affinities toward duplex, G-quadruplex, three-way junction, and mismatch DNA were determined, and derived FRET donor–acceptor proximities provide information on potential binding sites. Molecules characterized by this method demonstrate encouraging anticancer properties, including synergy with the PARP inhibitor Olaparib, and mechanistic studies indicate that [Ru(PIP)2(5,5′dmb)]2+ acts to block DNA replication fork progression.

A series of ligands have been synthesized based upon a polysubstituted 2-phenylquinoxaline core structure. These ligands introduce different combinations of fluorine and methyl substituents on both the phenyl and quinoxaline constituent rings. The resultant investigation of these species as cyclometalating agents for Ir(III) gave cationic complexes of the form [Ir(C^N) 2 (bipy)]PF 6 (where C^N = cyclometalating ligand; bipy = 2,2′-bipyridine). X-ray crystallographic studies were conducted on four complexes and each revealed the expected distorted octahedral geometry based upon a cis-C,C and trans-N,N ligand arrangement at Ir(III). Supporting computational studies predict that each of the complexes share the same general descriptions for the frontier orbitals. TD-DFT calculations suggest MLCT contributions to the lowest energy absorption and a likely MLCT/ILCT/LLCT nature to the emitting state. Experimentally, the complexes display tunable luminescence across the yellow-orange-red part of the visible spectrum (λ em = 579−655 nm).

Recycling of thermoelectric materials: thermoelectric leg and copper plates removed by targeted oxidation or thermoelectric legs removed by high-intensity ultrasonication.

Six disubstituted ligands based upon 2‐(2′‐pyridinyl/pyrazinyl)quinoline‐4‐carboxylic acids have been synthesised, solvent‐free, in one step from a range of commercially available isatin derivatives. These species behave as ancillary chelating ligands for Ir(III) complexes of the form [Ir(C^N)2(N^N)]PF6 (where C^N=cyclometalating ligand; N^N=2‐(2′‐pyridinyl/pyrazinyl)quinoline‐4‐carboxylic acids). An X‐ray crystallographic study on one complex shows a distorted octahedral geometry wherein a cis‐C,C and trans‐N,N coordination mode is observed for the cyclometalating ligands. DFT calculations predicted that variations in N^N ligand from 2,2′‐bipyridine to L1–6 should localise the LUMO on to the Ln ligand and that the complexes are predicted to display MLCT/LLCT character. All complexes displayed luminescence in the deep red part of the visible region (674–679 nm) and emit from triplet states, but with little apparent tuning as a function of L1–6. Further time‐resolved transient absorption spectroscopy supports the participation of these triplet states to the excited state character.

No abstract